Drugs: Pressemitteilungen - Kategorie - Seite 13

Drugs

Category / Pharmaceuticals & Biotech / Drugs


Medgenics to Present at the 15th Annual Needham Healthcare Conference

PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 03/30/16 -- (NYSE MKT: MDGN) today announced that Brian Piper, Chief Financial Officer, will present at the 15th Annual Needham Healthcare Conference in New York, ...

Nasdaq Grants Acasti Cure Period to Regain Compliance with Audit Committee Membership Requirements

LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 03/25/16 -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ: ACST)(TSX VENTURE: APO), an emerging biopharmaceutical company focused o ...

Knight Reports Fourth Quarter and Year-Ended December 31, 2015 Results

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 03/24/16 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, today repor ...

Knight Receives Dividend From Medison

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 03/23/16 -- Knight Therapeutics Inc. (TSX: GUD), through one of its wholly-owned subsidiaries ("Knight"), announced today receipt of a NIS 7.1 million ...

Marina Biotech Announces a License Agreement to Deliver a Genome Editing Technology

BOTHELL, WA: BOTHELL, WA -- (Marketwired) -- 03/16/16 -- Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today that they ...

IDT Biologika and Gallant Custom Laboratories Celebrate Expansion of North American Animal Health Operations

DESSAU, GERMANY and CAMBRIDGE, ON: Collaboration Positions IDT/Gallant as a Leader in Canadian Animal Health Market; Accelerates Development as Canada's Only "Vaccine-Only" Animal Health Company ...

Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech

NEW YORK, NY and BOTHELL, WA: Marina to Pursue Asset Purchase and Reverse Merger Opportunities ...

Knight Obtains Impavido Worldwide Rights

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 03/15/16 -- Knight Therapeutics Inc. (TSX: GUD), through one of its wholly-owned subsidiaries ("Knight"), announced today that it now owns worldwide ri ...

U.S. FDA Lifts Partial Clinical Hold on Medivation's Pidilizumab

SAN FRANCISCO, CA: Potentially Pivotal Phase II Trial in DLBCL and Other Studies May Proceed ...

VANC Pharmaceuticals Announces Corporate Update and Launch of Hema-Fer

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 03/07/16 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF), a pharmaceutical company focused ...

It's About the Money... Top 5 Global Pharma-Bio 2016 Project Investment Soars Past $4 Billion, an Industrial Info News Alert

SUGAR LAND, TX: SUGAR LAND, TX -- (Marketwired) -- 03/03/16 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- While the majority of people bemoan the cost of , few understand the cost ...

Theravance Biopharma to Report Fourth Quarter and Full Year 2015 Financial Results on March 9, 2016

DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 03/02/16 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial ...

Innoviva to Present at the Cowen & Company 36th Annual Health Care Conference 2016

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 03/01/16 -- Innoviva, Inc. (NASDAQ: INVA) announced today that Michael W. Aguiar, Innoviva's President and Chief Executive Officer, is scheduled to pr ...

Acasti Announces Management Appointment and Changes to the Board of Directors

LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 03/01/16 -- Acasti Pharma Inc. ("Acasti" or the "Corporation") (NASDAQ: ACST)(TSX VENTURE: APO), an emerging biopharmaceutical company focused o ...

FDA Accepts for Review Supplemental New Drug Application for XTANDI(R) (enzalutamide) Capsules in Metastatic Castration-Resistant Prostate Cancer With Data From Head-to-Head Studies of Enzalutamide Versus Bicalutamide

SAN FRANCISCO, CA and TOKYO, JAPAN: SAN FRANCISCO, CA and TOKYO, JAPAN -- (Marketwired) -- 02/22/16 -- Medivation, Inc. (NASDAQ: MDVN) and Astellas Pharma Inc. (TSE: 4503) today announced that the U.S. Food and Drug Administration (FDA ...

Cleveland BioLabs Reports 2015 Financial Results and Development Progress

BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 02/22/16 -- (NASDAQ: CBLI) today reported financial results and development progress for the fourth quarter and year ended December 31, 2015.Cleveland BioLabs reported ...

Marina Biotech Announces Evaluation and Option Agreement to Deliver a Genome Editing Technology

BOTHELL, WA: BOTHELL, WA -- (Marketwired) -- 02/18/16 -- Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases announced today that they ...

Marina Biotech to Explore Strategic Alternatives

BOTHELL, WA: BOTHELL, WA -- (Marketwired) -- 02/17/16 -- Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today that its ...


Seite 14 von 66:  « ..  13 14 15  16  17  18  19  20  21  22  .. » 66





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z